Sana Biotechnology Inc. logo

Sana Biotechnology Inc.

SANA | NASDAQ
Chart Builder DCF Calculator
$3.17
+$0.07 (+2.26%)
Sep 22, 2026, 2:43 PM ET · Market open

Market Data

Market Cap
$862.7M
Enterprise Value
$775.95M
Beta
2.13
Average Volume
3.3M
Shares Outstanding (Diluted)
295.67M
Shares Change YoY
24.02%
Institutional Ownership
59.32%
Exchange
NASDAQ
ISIN
US7995661045

Price Performance

Price Change 1M
-20.1%
Price Change 3M
-7.5%
Price Change 6M
0.0%
Price Change YTD
-26.0%
Price Change 1Y
-4.6%
Price Change 3Y
-19.1%
Price Change 5Y
-85.7%
1M CAGR (ann.)
-11.9%
1Y CAGR (ann.)
-5.8%
5Y CAGR (ann.)
-34.0%
All-Time CAGR
-35.0%

Valuation

PE Ratio
-4.13
Forward PE
N/A
PEG Ratio
-0.12
Forward PEG
0.30
PS Ratio
N/A
Forward PS
124.10
PB Ratio
5.58
P/FCF Ratio
-6.39
P/Adj. FCF Ratio
-5.46
P/OCF Ratio
-6.89
EV/Sales
N/A
EV/EBIT
-3.66
EV/EBITDA
-3.86
EV/FCF
-5.75
Earnings Yield
-24.2%
FCF Yield
-15.7%
Adj. FCF Yield
-18.3%

Financial Health

Net Cash
$160.49M
Total Debt
$73.74M
Cash & Short-Term Investments
$160.49M
Total Assets
$431.52M
Current Ratio
1.38
Quick Ratio
1.38
Debt / Equity Ratio
0.48
Debt / EBITDA
-0.37
Debt / FCF
-0.55
OCF / Debt
-1.79
Interest Coverage
0.00
Altman Z-Score
-5.98
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-16.9%

Returns

Return on Assets
-49.1%
Return on Equity
-134.5%
Return on Invested Capital
-64.5%
Return on Capital Employed
-67.6%
Return on Tangible Assets
-91.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
20.3%
EPS CAGR 5Y
19.9%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
37.1%
FCF CAGR 5Y
20.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
2.2%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.18
EPS Growth Est (next Q)
20.0%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
125.8%

Cash Flow

Operating Cash Flow
$-132.24M
Free Cash Flow
$-135.06M
Adj. Free Cash Flow
$-157.88M
FCF Per Share
-$0.46
OCF Per Share
-$0.45
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-2.39M
Operating Income
$-208M
EBITDA
$-200.99M
Net Income
$-211.82M
EPS (Diluted)
-$0.75
Revenue / Employee
N/A
Profit / Employee
$-1.49M
Employees
142

© 2026 bestshares.com. All rights reserved.